Reneo Pharmaceuticals, Inc. (RPHM) Reports Q2 Loss of $0.16
Tweet
Share
E-mailGet Alerts RPHM Hot Sheet
Join SI Premium – FREE
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) reported Q2 EPS of ($0.16), versus ($0.65) reported last year.
For earnings history and earnings-related data on Reneo Pharmaceuticals, Inc. (RPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
